BioMarin Pharmaceutical Inc. - Company & Market Research Reports

BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes. They are leaders in metabolic disease innovation with multiple products commercialized and a pipeline of product candidates to address unmet medical needs. BioMarin's headquarters are based in Novato, California, United States.


Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017

  • Report
  • 79 Pages
From
United States Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices - Product Thumbnail Image

United States Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • Report
  • 980 Pages
From
Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 - Product Thumbnail Image

Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018

  • Report
  • 1000 Pages
From
Protein Therapeutics: Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments, Global Market - Product Thumbnail Image

Protein Therapeutics: Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments, Global Market

  • Report
  • 250 Pages
From
Biotechnology and Pharmaceuticals Report - Product Thumbnail Image

Biotechnology and Pharmaceuticals Report

  • Report
  • 20 Pages
From
Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence - Product Thumbnail Image

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence

  • Report
  • 171 Pages
From
Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence - Product Thumbnail Image

Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence

  • Report
  • 170 Pages
From
Global Markets and Manufacturing Technologies for Protein Drugs - Product Thumbnail Image

Global Markets and Manufacturing Technologies for Protein Drugs

  • Report
  • 176 Pages
From
Breast Cancer: New targeted therapies transform treatment - KOL Insight - Product Thumbnail Image

Breast Cancer: New targeted therapies transform treatment - KOL Insight

  • Report
  • 153 Pages
From
Peptide Therapeutics in Metabolic Disorders, 2016 - 2025 - Product Thumbnail Image

Peptide Therapeutics in Metabolic Disorders, 2016 - 2025

  • Report
  • 436 Pages
From
Global Genetic Disorders Drugs Market to 2023 - A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease - Product Thumbnail Image

Global Genetic Disorders Drugs Market to 2023 - A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease

  • Report
  • 160 Pages
From
Market Spotlight: Duchenne Muscular Dystrophy (DMD) - Product Thumbnail Image

Market Spotlight: Duchenne Muscular Dystrophy (DMD)

  • Report
  • 35 Pages
From
Duchenne Muscular Dystrophy - Pipeline Review, H1 2018 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Pipeline Review, H1 2018

  • Report
  • 305 Pages
From
Duchenne Muscular Dystrophy (DMD): Competitive Landscape to 2026 - Product Thumbnail Image

Duchenne Muscular Dystrophy (DMD): Competitive Landscape to 2026

  • Report
  • 49 Pages
From
Glycobiology: Global Markets for Diagnostics and Therapeutics - Product Thumbnail Image

Glycobiology: Global Markets for Diagnostics and Therapeutics

  • Report
  • 137 Pages
From
Global Biosimilars Market, 2015 - 2025 - Product Thumbnail Image

Global Biosimilars Market, 2015 - 2025

  • Report
  • 462 Pages
From
Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market - Product Thumbnail Image

Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market

  • Report
  • 176 Pages
From
Metastatic Breast Cancer - Pipeline Review, H1 2015 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Review, H1 2015

  • Report
  • 866 Pages
From
50 Key Biopharmaceutical and Biotechnology Companies - Product Thumbnail Image

50 Key Biopharmaceutical and Biotechnology Companies

  • Report
  • 201 Pages
From
Biopharmaceuticals - Global Strategic Business Report - Product Thumbnail Image

Biopharmaceuticals - Global Strategic Business Report

  • Report
  • 730 Pages
From
Loading Indicator
adroll